IDEAS home Printed from https://ideas.repec.org/a/sae/envira/v25y1993i12p1815-1838.html
   My bibliography  Save this article

Collaborative Integration in the Canadian Pharmaceutical Industry

Author

Listed:
  • M J Anderson

    (Department of Geography, Queen's University, Kingston, Ontario, Canada K7L 3N6)

Abstract

Over the course of the 1980s, companies attempted to develop new organisational strategies to balance competition with collaboration. Although a variety of theoretical frameworks acknowledged this development there have been very few empirical studies in which the nature and extent of this collaborative integration and the implications for industries in the 1990s have been examined. In this paper, the Canadian pharmaceutical industry is used as the empirical context for an examination of collaboration. The author focuses on the relationship between small and large firms, biotechnology-based companies, and university research and argues that these collaborative linkages need to be more firmly developed in our theoretical discussions if we are to make sense of the corporate world in the 1990s.

Suggested Citation

  • M J Anderson, 1993. "Collaborative Integration in the Canadian Pharmaceutical Industry," Environment and Planning A, , vol. 25(12), pages 1815-1838, December.
  • Handle: RePEc:sae:envira:v:25:y:1993:i:12:p:1815-1838
    DOI: 10.1068/a251815
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1068/a251815
    Download Restriction: no

    File URL: https://libkey.io/10.1068/a251815?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Lynn Krieger Mytelka & Michel Delapierre, 1987. "The Alliance Strategies of European Firms in the Information Technology Industry and the Role of ESPRIT," Journal of Common Market Studies, Wiley Blackwell, vol. 26(2), pages 231-253, December.
    2. Peter Temin, 1979. "Technology, Regulation, and Market Structure in the Modern Pharmaceutical Industry," Bell Journal of Economics, The RAND Corporation, vol. 10(2), pages 429-446, Autumn.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. repec:rdg:wpaper:em-dp2007-43 is not listed on IDEAS
    2. Rajneesh Narula & Grazia D. Santangelo, 2007. "Location and R&D Alliances in the European ICT Industry," DRUID Working Papers 07-05, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
    3. Hartnell, Gaynor, 1996. "The innovation of agrochemicals: regulation and patent protection," Research Policy, Elsevier, vol. 25(3), pages 379-395, May.
    4. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
    5. Dimitris Assimakopoulos, 2002. "IT Innovation within the Esprit and IST Programs. Some Evidence from the UK," Post-Print hal-00452340, HAL.
    6. Hulsink, W., 1994. "The single European telecoms market : From state monopolies & national champions to an oligopoly of Euro-nationals and global alliances?," WORC Paper 94.04.030/3, Tilburg University, Work and Organization Research Centre.
    7. Pakes, Ariel & Nitzan, Shmuel, 1983. "Optimum Contracts for Research Personnel, Research Employment, and the Establishment of "Rival" Enterprises," Journal of Labor Economics, University of Chicago Press, vol. 1(4), pages 345-365, October.
    8. Furman, Jeffrey L. & MacGarvie, Megan J., 2007. "Academic science and the birth of industrial research laboratories in the U.S. pharmaceutical industry," Journal of Economic Behavior & Organization, Elsevier, vol. 63(4), pages 756-776, August.
    9. Peters, Lois & Groenewegen, Peter & Fiebelkorn, Nico, 1998. "A comparison of networks between industry and public sector research in materials technology and biotechnology," Research Policy, Elsevier, vol. 27(3), pages 255-271, July.
    10. Santangelo, Grazia D., 2000. "Corporate strategic technological partnerships in the European information and communications technology industry," Research Policy, Elsevier, vol. 29(9), pages 1015-1031, December.
    11. Athreye, Suma & Godley, Andrew, 2008. "Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s," MERIT Working Papers 2008-051, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    12. Narula, Rajneesh & Duysters, Geert, 2004. "Globalisation and trends in international R&D alliances," Journal of International Management, Elsevier, vol. 10(2), pages 199-218.
    13. F. M. Scherer, 1993. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry," Journal of Economic Perspectives, American Economic Association, vol. 7(3), pages 97-115, Summer.
    14. Narula, Rajneesh & Santangelo, Grazia D., 2009. "Location, collocation and R&D alliances in the European ICT industry," Research Policy, Elsevier, vol. 38(2), pages 393-403, March.
    15. Starbatty, Joachim & Vetterlein, Uwe, 1994. "Forschungs- und Technologiepolitik der Europäischen Union," Tübinger Diskussionsbeiträge 39, University of Tübingen, School of Business and Economics.
    16. Ariel Pakes & Zvi Griliches, 1984. "Patents and R&D at the Firm Level: A First Look," NBER Chapters, in: R&D, Patents, and Productivity, pages 55-72, National Bureau of Economic Research, Inc.
    17. Bhaven N. Sampat, 2015. "Intellectual property rights and pharmaceuticals: The case of antibiotics," WIPO Economic Research Working Papers 26, World Intellectual Property Organization - Economics and Statistics Division.
    18. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
    19. Abbott, Thomas III, 1995. "Price regulation in the pharmaceutical industry: Prescription or placebo?," Journal of Health Economics, Elsevier, vol. 14(5), pages 551-565, December.
    20. P E Wells & P N Cooke, 1991. "The Geography of International Strategic Alliances in the Telecommunications Industry: The Cases of Cable and Wireless, Ericsson, and Fujitsu," Environment and Planning A, , vol. 23(1), pages 87-106, January.
    21. Cohen, Wesley M., 2010. "Fifty Years of Empirical Studies of Innovative Activity and Performance," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 129-213, Elsevier.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:envira:v:25:y:1993:i:12:p:1815-1838. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.